超早期软通道微创颅内血肿清除术治疗高血压脑出血的可行性及效果分析

Feasibility and effectiveness of ultra early soft channel minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage

目的探析超早期软通道微创颅内血肿清除术治疗高血压脑出血的可行性及效果，旨在为今后临床治疗高血压脑出血提供参考依据。方法前瞻性选取2010年5月至2015年9月120例高血压脑出血患者为研究对象，采用随机数字法将其分为对照组和研究组，对照组采用常规治疗，研究组采用超早期（发病至手术时间〈6 h）软通道微创颅内血肿清除术，观察两组患者神经功能缺损情况、颅内血肿及血肿周围的水肿变化。结果两组患者治疗后NIHSS评分较治疗前明显降低，且对照组较研究组降低程度更为明显（P〈0.05）；治疗后7、14 d，研究组血肿量及血肿周围水肿量均明显低于对照组（P〈0.05）。结论对高血压脑出血治疗采用超早期软通道微创颅内血肿清除术，可行性高，疗效确切，值得临床应用与推广。

ObjectiveTo study the feasibility and effect of ultra early soft channel minimally invasive intracranial hematoma removal in the treatment of hypertensive cerebral hemorrhage, and to provide reference for clinical treatment of hypertensive cerebral hemorrhage in the future.MethodsA total of 120 cases of hypertensive cerebral hemorrhage patients from May 2010 to September 2015 were selected as the research objects, and were randomly divided into study group and control group. The patients in the control group were given conventional therapy, and the patients in the study group were treated by ultra early （the time from occuring to operation less than 6 h） soft channel minimally invasive evacuation of intracranial hematoma. The neural function defects of patients, intracranial hematoma and hematoma surrounding edema were observed.ResultsAfter treatment, the NIHSS scores of the two groups were significantly lower than before treatment, and those of the control group was significantly lower than those of the study group （P〈 0.05）. After treatment of 7 days and 14 days, the amount of hematoma and edema around the hematoma in the study group were significantly lower than those in the control group （P〈0.05）.ConclusionsEarly soft channel minimally invasive intracranial hematoma removal in the treatment of hypertensive cerebral hemorrhage, has high feasibility, exact effect, so it is worth clinical application and promotion.